Elyzol

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Elyzol

Property Description
Active ingredient Metronidazole (INN)
Form Oral tablets, topical gels, intravenous solutions
Pharmacological class Nitroimidazole antimicrobial
Common use Targeting specific anaerobic bacteria and protozoa
Origin Synthetic compound

Defining Elyzol: Classification and Chemical Origin

Elyzol is a pharmaceutical product primarily containing the active ingredient Metronidazole, classifying it as both a synthetic antibacterial and a potent antiprotozoal agent. This substance belongs to the highly specialized nitroimidazole antimicrobial class, a designation recognized in pharmacological literature. As a derivative of 2-methyl-5-nitro-1H-imidazole-1-ethanol, Metronidazole is synthesized, rather than derived from a natural source. Due to its essential efficacy against a wide range of susceptible pathogens, Metronidazole is globally recognized on the World Health Organization’s Model List of Essential Medicines.

Composition and Available Forms of Metronidazole

The therapeutic core of the medicine is Metronidazole, often utilized as the single active substance, though formulations may also employ the derivative Metronidazole Benzoate, particularly in some oral suspensions. The drug is designed for multiple routes of administration, ensuring versatility for both systemic and localized infections. It is manufactured in various dosage form(s), including oral tablets and capsules for ingestion, as well as specialized local delivery systems like topical gels, creams, and intravenous injection solutions. This breadth of presentation ensures the key therapeutic agent can be delivered effectively via oral, topical, vaginal, or intravenous routes, depending on the requirement.

The General Purpose of This Essential Antimicrobial

The general purpose of Metronidazole-based medicines is to act as a crucial defense mechanism for the body, selectively eliminating infections caused by targeted anaerobic bacteria and protozoal organisms. The drug functions as a prodrug that is activated only in the presence of these pathogens, allowing it to exert its therapeutic effect precisely where needed. Beyond its direct microbe-killing mechanism, the substance is also clinically recognized for its capacity to modulate inflammatory responses in affected tissues. This dual action is vital in treating infections, as the medicine assists in reducing the irritation associated with the body’s reaction to the microbial invasion while clearing the pathogen.

What side effects are possible with Elyzol?

Possible Side Effects and Safety Information

The official safety profile for Elyzol, which contains metronidazole, categorizes possible adverse reactions primarily according to their frequency and the system-organ class affected, as defined by regulatory authorities.

Commonly Documented Adverse Reactions

The most commonly reported side effects listed in official labeling include gastrointestinal disturbances such as nausea, abdominal discomfort, vomiting, and diarrhea. A distinctive and frequently noted reaction is a persistent metallic taste in the mouth. Headache and dizziness are also included among the common effects documented in the nervous system classification.

Serious Adverse Reactions and Safety Patterns

The official labeling highlights several serious adverse reactions, which are generally rare but clinically significant. These include disorders of the Nervous System such as seizures, encephalopathy, and peripheral neuropathy (which may be associated with prolonged use or high cumulative doses). Rare but serious reactions concerning the Blood and Lymphatic System, such as agranulocytosis and neutropenia, are also documented. Severe reactions concerning the liver, including hepatotoxicity, are officially documented in specific circumstances.

Safety Considerations for Special Populations

Regulatory documents include specific safety constraints for certain patient groups. Individuals with severe hepatic impairment (severe liver disease) are subject to specific safety limitations due to the drug's metabolism, which increases the potential for accumulation. Caution is also advised in patients with a history of blood disorders or pre-existing Central Nervous System (CNS) disease, as these conditions may increase the risk of certain adverse events.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdosage involving Metronidazole, the active ingredient in Elyzol, has been documented in cases resulting from massive single ingestion or prolonged exposure to high doses. The officially recognized acute manifestations of overexposure can include gastrointestinal symptoms such as nausea and vomiting, and a lack of muscular coordination known as ataxia.

Severe Outcomes and Regulatory Guidance

Of significant regulatory concern are severe neurotoxic effects that have been reported, including seizures and peripheral neuropathy. The development of these serious neurological manifestations is associated with chronic high-level overexposure and requires immediate professional medical intervention.

Emergency Management Strategy

Regulatory documents emphasize that there is no specific antidote available to reverse the effects of Metronidazole overdose. Therefore, the mandated management strategy consists solely of symptomatic and supportive treatment to address the clinical effects as they manifest. In cases of massive overdose or suspicion of severe neurotoxicity, urgent medical attention must be sought immediately. A specific procedural intervention documented for Metronidazole removal in severe scenarios is hemodialysis, which can remove a significant portion of the compound from the bloodstream.

Therapeutic Uses of Elyzol

What Elyzol Treats: Main Uses and Benefits

This medication is applied in clinical settings marked by infections involving susceptible anaerobic bacteria and specific protozoal organisms. It is commonly used to address serious systemic conditions, such as infections of the blood and critical organs, and localized issues, including certain gynecological infections, dental abscesses, and complicated skin ulcers. It is relevant in addressing conditions such as amebiasis, Giardiasis, and Trichomoniasis.

This use is relevant for managing symptoms that interfere with daily functioning across various domains. It contributes to improved comfort during periods of heightened symptoms related to bacterial invasion or parasitic distress. A relevant clinical application is its preventive use before or during high-risk surgical procedures to reduce the likelihood of postoperative infection. This provides support that helps ease the overall symptom burden during the postoperative phase.

“Therapy in these situations provides support that helps ease the overall symptom burden and offers symptomatic relief that helps patients cope more steadily with difficult episodes.”

Quick Fact: Relief for Localized and Systemic Discomfort The medication is relevant for easing symptoms related to systemic imbalance, such as fever associated with deep infections, as well as localized symptoms related to inflammatory or irritative states like pain and discharge.

Regulatory References

  1. MedlinePlus Drug Information

Eligibility and Restrictions for Use

Elyzol, containing metronidazole, is strictly governed by regulatory eligibility rules that define who can use the medicine and under what conditions. These rules are based on formal government labeling and prescribing information.

Populations For Whom Use Is Contraindicated

Use is absolutely prohibited in patients with a known history of hypersensitivity to metronidazole or other nitroimidazole derivatives. The medicine is also contraindicated in patients with Cockayne syndrome, a genetic disorder, due to the risk of severe liver failure.

Furthermore, the use of this medicine is prohibited in patients who have taken Disulfiram within the last two weeks, and in those who consume alcohol or products containing propylene glycol during therapy and for at least three days after the final dose.

Restricted or Conditional Use

Population Group Regulatory Status
Severe Hepatic Impairment (Child-Pugh C) Dose reduction (50%) is recommended due to impaired clearance.
End-Stage Renal Disease (ESRD) Monitoring is recommended for accumulation of metabolites.
First Trimester of Pregnancy Use is not recommended or considered contraindicated by some authorities.
Breastfeeding Not recommended during systemic therapy due to excretion into breast milk.
Pediatric Population Use is established for certain indications, but safety and effectiveness are not established for all forms.

Eligibility is defined by these constraints, limiting use to those populations where the risk profile, organ function, and physiological status align with the official prescribing information.

What should I know about interactions with other medicines?

Elyzol's active ingredient, metronidazole, has several documented interactions with other medications and substances. Patients should be aware of these potential combinations to ensure safe use.

Major Interactions (Avoid Combination)

The simultaneous use of Elyzol with the following is contraindicated:

  • Alcohol/Propylene Glycol: Consumption of any alcoholic beverages or products containing propylene glycol must be avoided during therapy and for at least three days after the final dose. This combination can trigger a severe disulfiram-like reaction, characterized by flushing, nausea, vomiting, headaches, and abdominal cramps.
  • Disulfiram: Elyzol should not be administered to a patient who has taken disulfiram within the last two weeks. This interaction has been associated with the development of psychotic reactions, including confusion and hallucinations.

Interactions Requiring Close Monitoring

Other medicines may require dose adjustments or intensified monitoring when combined with Elyzol:

  • Oral Anticoagulants (e.g., Warfarin): Elyzol can potentiate the effects of blood-thinners, increasing the risk of bleeding. Close monitoring of the patient's International Normalized Ratio (INR) is necessary, and the anticoagulant dose may need adjustment.
  • Lithium: The concurrent use of Elyzol can raise the blood concentration of lithium, potentially leading to toxicity. Serum lithium levels must be closely monitored.
  • Cimetidine: This drug can reduce the rate at which Elyzol is cleared from the body, leading to higher levels of Elyzol in the bloodstream and a greater risk of adverse effects.
  • Certain Antiepileptics (e.g., Phenytoin, Phenobarbital): These medications may speed up Elyzol's metabolism, resulting in lower blood concentrations of Elyzol and possibly reduced efficacy.
  • Busulfan: Elyzol can increase the plasma concentration of busulfan, raising the risk of serious toxicity from that medication.

Mechanism of Action

Selective Activation and Destruction of Microbial DNA

Metronidazole's mechanism results in selective toxicity due to the requirement for specific electron transfer conditions inside target organisms. The molecule acts as an inert prodrug that undergoes activation only in the low-oxygen, low-redox conditions of obligate anaerobic bacteria and certain protozoa. Within these organisms, electrons are donated to the drug's nitro group by microbial electron transport proteins, forming highly reactive free radicals. This mechanistic cascade leads to damage of the microbial DNA, blocking replication and synthesis, which is the molecular event that results in the death (lysis) of the targeted pathogen.

Non-Microbial Modulation of Inflammatory Pathways

In addition to its direct anti-pathogen effect, the drug engages mechanisms that influence host physiology. Metronidazole modulates local immune responses by interfering with the generation of pro-inflammatory mediators like cytokines at the site of biological disruption. This action results in the reduction of pro-inflammatory mediators and the modulation of inflammatory cascades within the affected tissues.

Dosage and Administration Information

How Elyzol is Used: Official Administration Guidelines

Elyzol, which contains metronidazole, is administered according to established protocols to ensure precise delivery. Its use is standardized across multiple forms and routes to treat systemic or localized infections.

Approved Administration Methods

The medicine is available for diverse applications, including oral tablets or capsules for ingestion, intravenous (IV) infusion for serious systemic conditions, and topical/vaginal formulations for localized treatment. The IV form is typically used initially in severe cases, followed by a transition to the oral form when a patient's condition allows, a process known as sequential therapy.

Standard Dosing and Frequency

Dosing is based on the specific indication, with adult regimens defined numerically:

  • Serious Anaerobic Infections: The maintenance regimen is typically 7.5 mg/ kg administered every 6 hours (q6hr).
  • Protozoal Infections: Oral doses are commonly 250 mg or 500 mg taken two or three times daily (BID or TID) for a set course, often lasting 5 to 10 days.
  • Surgical Prophylaxis: The IV infusion is usually given as a single dose immediately before surgery and is discontinued within 12 hours post-operation.

Key Administration Rules

Specific instructions govern the proper intake of different forms:

  • Oral Timing: Immediate-release tablets may be taken with or without food. However, extended-release (ER) tablets must be taken on an empty stomach, either 1 hour before or 2 hours after a meal, and must be swallowed whole without crushing or chewing.
  • IV Infusion: Must be administered as a slow IV infusion lasting 30 to 60 minutes, ensuring appropriate delivery conditions are met.
  • Dose Adjustment: Guidelines mandate specific dosage reductions (e.g., 50%) for individuals with severe hepatic (liver) impairment and recommend a supplementation dose after hemodialysis for patients with end-stage renal disease.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Elyzol

Evidence for Infections Caused by Protozoa (Trichomoniasis and Amebiasis)

Metronidazole was studied for conditions associated with acute or disruptive episodes caused by certain protozoa. For trichomoniasis, randomized trials examined whether single-dose and multi-day schedules were associated with different rates of infection recurrence. Studies monitored laboratory measurements of parasite clearance at follow-up. Some trials reported patterns where individuals assigned to the multi-day regimen were less likely to test positive for the parasite at post-treatment evaluation compared to the single-dose group. Scientific reviews consistently reported high rates of reinfection or recurrence for women after initial treatment.

Evidence for Systemic and Local Anaerobic Bacterial Infections

Research examined metronidazole in populations with conditions involving periods of heightened symptoms caused by susceptible anaerobic bacteria. Systematic reviews monitored findings from studies evaluating outcomes when the drug was administered at different dosing intervals (e.g., every 8 hours versus every 12 hours) in hospitalized adult patients. Findings from meta-analyses of existing retrospective studies show patterns related to comparable outcomes between the different dosing intervals when evaluating the need to escalate antibiotic therapy. However, some individual studies observed a higher frequency of clinical failure regarding the longer dosing interval.

Evidence for Bacterial Vaginosis (BV)

Metronidazole was evaluated in short-term randomized controlled trials for conditions like bacterial vaginosis (BV). Research tracked the resolution of symptoms over approximately two to four weeks post-treatment. While short-term studies monitored changes in symptoms, longitudinal research consistently reported high rates of recurrence—often between 50% and 80%—within 6 to 12 months. Research is ongoing to explore potential mechanisms for these high recurrence rates, including studies related to bacterial resistance or the persistence of biofilm.

Frequently Asked Questions (FAQ)

Common questions about Elyzol (FAQ)


Q: How quickly is Elyzol supposed to start working?

According to clinical data, the active ingredient in Elyzol is quickly absorbed, often within an hour or two of administration. However, official information suggests that noticing clinical improvement may take a couple of days.


Q: How long do the effects of Elyzol typically last?

The active ingredient, metronidazole, has an average elimination half-life of approximately eight hours in healthy adults. This means it generally takes about 44 hours, or over three days, for the medicine to be cleared from the system after the final dose is taken.


Q: What happens if I miss a dose of Elyzol?

Official guidance states that if a dose is missed, the dose may be taken as soon as it is remembered. If the time for the next scheduled dose is near, taking a double dose is not advised, and continuing the regular schedule is recommended.


Q: Can Elyzol cause stomach upset?

Yes, one of the most commonly documented adverse reactions involves the digestive system. Official safety information lists this as gastrointestinal disturbances, which includes symptoms such as nausea, vomiting, diarrhea, and abdominal discomfort.


Q: Does Elyzol interact with common pain relievers like ibuprofen?

Official regulatory documents do not typically list a specific interaction with common over-the-counter pain relievers, such as non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen. As a standard precaution, patients are advised to inform their doctor or dentist of all medicines they are currently taking.


Q: Does Elyzol affect the effectiveness of birth control?

Studies and official product information indicate that the medicine may reduce the effectiveness of some estrogen-containing oral contraceptives (birth control pills). This could increase the risk of an unintended pregnancy or cause breakthrough bleeding. Patients should discuss this possibility with a healthcare provider.


Q: Can pregnant women use Elyzol?

Use of this medicine is generally not recommended during the first trimester of pregnancy. However, most available regulatory studies suggest a low risk of harm to the fetus when the medicine is used under medical guidance during the second and third trimesters, when determined to be appropriate.


Q: Is Elyzol appropriate for children or teenagers?

Use of the medicine is established for treating certain infections in the pediatric population. However, the appropriate dosage and exact use are highly specific to the child’s age, weight, and the condition being treated, which is determined on a case-by-case basis by a healthcare professional.


Q: Can I use Elyzol if I have a history of liver problems?

Official guidance notes that patients with severe hepatic (liver) impairment typically require a dose reduction because the drug’s clearance can be affected. For patients with mild to moderate liver impairment, dose adjustment is not typically required, but monitoring for adverse events is noted in the label.


Q: Is it safe to use Elyzol if I am taking a blood thinner?

Elyzol may potentiate (increase the effect of) certain blood thinners, such as Warfarin and other oral coumarin anticoagulants. This interaction may increase the risk of bleeding. Regulatory guidance emphasizes the importance of closely monitoring blood clotting levels when these medicines are used together.


Q: What is the purpose of the gel/paste formulation of Elyzol?

The topical gel and paste formulations are specifically designed for localized application. This method is used to deliver a high concentration of the medicine directly to the site of infection, such as in gum pockets, while minimizing the medicine’s absorption into the rest of the body.


Q: Does the drug clearance process of Elyzol depend on kidney function?

The drug's major route of elimination is via the urine. While official prescribing information notes that decreased kidney function does not alter the single-dose pharmacokinetics (how the body handles the drug), monitoring is recommended for patients with end-stage renal disease.


Q: Is the use of Elyzol limited to specific types of periodontal disease?

Yes, the official indication for the medicine is for treating infections that are proven or strongly suspected to be caused by susceptible obligate anaerobic bacteria and certain protozoa. It is not generally effective against all bacteria or conditions that may contribute to gum disease.


Q: Is Elyzol the same as metronidazole tablets?

Elyzol is a brand name product that contains the active ingredient metronidazole. Metronidazole is the generic name for the substance and is available under other brand names or as a generic product in different forms, including oral tablets and specialized localized gels/pastes.


Q: Is there an issue with using Elyzol and mouthwash at the same time?

Some common mouthwashes contain alcohol or propylene glycol. Regulatory warnings state that these substances must be strictly avoided during therapy and for three days afterward due to the risk of a severe disulfiram-like reaction. Patients must check the product label of any mouthwash used.


Q: Are there any food or drink restrictions while using Elyzol?

Yes. Patients must strictly avoid all alcohol and any products containing propylene glycol (a common food additive) during therapy and for at least three days after the final dose. This restriction is necessary to prevent a severe adverse reaction.


Q: Is Elyzol a brand name for metronidazole?

Yes, Elyzol is a specific brand name for a product containing the active ingredient metronidazole. Metronidazole is also available under various other brand names or as a generic product in different dosage forms.


Q: Why is the drug given directly into the gum pockets?

Topical and localized delivery systems, such as gels or pastes, are used to maximize the drug’s effectiveness by ensuring it reaches a high concentration at the specific site of infection, such as the gum pockets. This method is also intended to minimize the amount of medicine that is absorbed systemically into the rest of the body.


Q: Can older adults use Elyzol without issue?

The official prescribing information contains a section on Geriatric Use. Regulatory documents advise that dosing for older adults should be approached cautiously, often starting at the lower end of the dosing range, due to the potential for decreased kidney or liver function.


Q: Is it true that Elyzol can interact with some antifungal medications?

Official labeling notes that using this medicine may lead to an overgrowth of Candida (a type of fungus), and a separate antifungal agent may be needed to clear the new infection.


Q: Can Elyzol interact with diabetes medications?

Official regulatory documents do not list specific warnings for an interaction between metronidazole and common medications used to treat diabetes. It is a standard practice to inform a doctor or dentist of all medications being taken.


Q: Is Elyzol effective against all types of bacteria that cause gum disease?

No. Official documents specify that the drug is only effective against a narrow spectrum of organisms: obligate anaerobic bacteria and certain protozoa. It is not designed to treat infections caused by aerobic bacteria or viruses.


Q: Is there a risk of resistance developing from using Elyzol?

Yes, regulatory warnings indicate that there is a potential for the development of resistance against the active ingredient. Official guidance emphasizes that the medication is intended to be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria.


Q: Is Elyzol used for preventative purposes?

Yes. The active ingredient in Elyzol is indicated for both treating existing infections and for prophylactic use, which means preventing an infection before it occurs. This includes preventing post-operative infections in certain surgical procedures.


Q: Are there any reported interactions between Elyzol and vaccinations?

Yes, metronidazole may interact with certain live vaccines, such as the oral typhoid vaccine, and can reduce their effectiveness. Official guidance suggests separating the administration of the medicine and the vaccine by a specific time interval to avoid reducing the vaccine's effectiveness.


Q: What is the half-life of the active ingredient in Elyzol?

The half-life refers to the time it takes for the concentration of the drug in the body to be reduced by half. The active ingredient, metronidazole, has an average elimination half-life of approximately eight hours in healthy adults.


Q: Does Elyzol contain any gluten or common allergens?

Official regulatory documents list the inactive ingredients for specific formulations, such as lactose in the extended-release tablet. However, these documents do not typically confirm the complete absence of all common allergens or gluten.

How should Elyzol be stored and disposed of?

The official storage and disposal requirements for Metronidazole (the active ingredient in Elyzol) are mandatory for maintaining product stability and ensuring safety.

Storage & Disposal Scope

Scope Item Official Regulatory Requirement
Labeled storage temperature requirements: Store at controlled room temperature (e.g., below 25 C or 30 C).
Light/moisture protection requirements: Must be protected from light.
Handling requirements: DO NOT FREEZE (for specific liquid/injection forms).
Child-protection storage requirements: Must be kept out of the sight and reach of children.
Disposal instructions: Dispose of unused product according to local pharmaceutical waste regulations; do not dispose of via wastewater (i.e., do not flush).

Regulatory documents define storage by mandating temperature limits and light protection, requiring the product to be kept in a tightly closed, original container. Disposal is constrained by environmental rules, directing consumers to official drug take-back programs.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Elyzol found in:

A-Z Index: